{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:41:25Z","timestamp":1787740885230,"version":"build-2784847793"},"reference-count":50,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2017.00114","type":"journal-article","created":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T23:51:15Z","timestamp":1496274675000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":97,"title":["Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH\u2009+\u2009Luteinizing Hormone, Human Menopausal Gonadotropin or FSH\u2009+\u2009Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the \u201cPersonalized\u201d Medicine Era: A Meta-analysis"],"prefix":"10.3389","volume":"8","author":[{"given":"Daniele","family":"Santi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livio","family":"Casarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Alviggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Simoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,6,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1210\/edrv.23.2.0462","article-title":"The lutropin\/choriogonadotropin receptor, a 2002 perspective","volume":"23","author":"Ascoli","year":"2002","journal-title":"Endocr Rev"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e46682","DOI":"10.1371\/journal.pone.0046682","article-title":"LH and hCG action on the same receptor results in quantitatively and qualitatively different intracellular signalling","volume":"7","author":"Casarini","year":"2012","journal-title":"PLoS One"},{"key":"B3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.mce.2015.12.008","article-title":"Follicle-stimulating hormone potentiates the steroidogenic activity of chorionic gonadotropin and the anti-apoptotic activity of luteinizing hormone in human granulosa-lutein cells in vitro","volume":"422","author":"Casarini","year":"2016","journal-title":"Mol Cell Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1185\/030079902125001498","article-title":"Comparison of recombinant human luteinising hormone (r-hLH) and human menopausal gonadotropin (hMG) in assisted reproductive technology","volume":"19","author":"Baer","year":"2003","journal-title":"Curr Med Res Opin"},{"key":"B5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2014.05.027","article-title":"Cryopreservation of human embryos and its contribution to in vitro fertilization success rates","volume":"102","author":"Wong","year":"2014","journal-title":"Fertil Steril"},{"key":"B6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1477-7827-10-9","article-title":"Hormonal, functional and genetic biomarkers in controlled ovarian stimulation: tools for matching patients and protocols","volume":"10","author":"Alviggi","year":"2012","journal-title":"Reprod Biol Endocrinol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/978-1-4939-0659-8_15","article-title":"IVF stimulation: protocols for poor responders","volume":"1154","author":"Davis","year":"2014","journal-title":"Methods Mol Biol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3978\/j.issn.2305-5839.2015.04.09","article-title":"Comparison of different stimulation protocols used in in vitro fertilization: a review","volume":"3","author":"Shrestha","year":"2015","journal-title":"Ann Transl Med"},{"key":"B9","first-page":"121","article-title":"Induction of follicular growth, ovulation and luteinization in the human ovary","volume":"22","author":"Edwards","year":"1975","journal-title":"J Reprod Fertil Suppl"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1093\/humrep\/deh369","article-title":"Recombinant human LH supplementation during GnRH antagonist administration in IVF\/ICSI cycles: a prospective randomized study","volume":"19","author":"Cedrin-Durnerin","year":"2004","journal-title":"Hum Reprod"},{"key":"B11","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.fertnstert.2011.06.069","article-title":"Low-dose human chorionic gonadotropin may improve in vitro fertilization cycle outcomes in patients with low luteinizing hormone levels after gonadotropin-releasing hormone antagonist administration","volume":"96","author":"Propst","year":"2011","journal-title":"Fertil Steril"},{"key":"B12","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S1472-6483(10)61991-8","article-title":"LH in the follicular phase: neither too high nor too low","volume":"12","author":"Balasch","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/j.fertnstert.2007.05.039","article-title":"Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patients","volume":"89","author":"Hompes","year":"2008","journal-title":"Fertil Steril"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1093\/humrep\/der106","article-title":"Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles","volume":"26","author":"Sunkara","year":"2011","journal-title":"Hum Reprod"},{"key":"B16","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/humrep\/dev316","article-title":"Conventional ovarian stimulation and single embryo transfer for IVF\/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?","volume":"31","author":"Drakopoulos","year":"2016","journal-title":"Hum Reprod"},{"key":"B17","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1093\/humrep\/dew358","article-title":"Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols","volume":"32","author":"Toftager","year":"2017","journal-title":"Hum Reprod"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1093\/humrep\/17.8.2009","article-title":"Modulation of folliculogenesis and steroidogenesis in women by graded menotrophin administration","volume":"17","author":"Filicori","year":"2002","journal-title":"Hum Reprod"},{"key":"B19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0301-2115(02)00476-1","article-title":"A pilot study of the use of low dose human menopausal gonadotropin in ovulation induction","volume":"109","author":"Ku","year":"2003","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.fertnstert.2004.06.041","article-title":"Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques","volume":"82","author":"Ferraretti","year":"2004","journal-title":"Fertil Steril"},{"key":"B21","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3109\/09513591003632175","article-title":"Lyophilised hMG versus rFSH in women with unexplained infertility undergoing a controlled ovarian stimulation with intrauterine insemination: a prospective, randomised study","volume":"26","author":"Kocak","year":"2010","journal-title":"Gynecol Endocrinol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.fertnstert.2010.08.044","article-title":"A prospective randomized noninferiority study comparing recombinant FSH and highly purified menotropin in intrauterine insemination cycles in couples with unexplained infertility and\/or mild-moderate male factor","volume":"95","author":"Sagnella","year":"2011","journal-title":"Fertil Steril"},{"key":"B23","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ejogrb.2013.03.002","article-title":"Advantages of recombinant follicle-stimulating hormone over human menopausal gonadotropin for ovarian stimulation in intrauterine insemination: a randomized clinical trial in unexplained infertility","volume":"169","author":"Rashidi","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/humrep\/deu302","article-title":"Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women >\/=35 years: a RCT","volume":"30","author":"Moro","year":"2015","journal-title":"Hum Reprod"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1210\/jc.2002-021946","article-title":"Absence of exon 10 of the human luteinizing hormone (LH) receptor impairs LH, but not human chorionic gonadotropin action","volume":"88","author":"Muller","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1111\/febs.12718","article-title":"Differences between lutropin-mediated and choriogonadotropin-mediated receptor activation","volume":"281","author":"Grzesik","year":"2014","journal-title":"FEBS J"},{"key":"B27","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3389\/fendo.2015.00140","article-title":"Differences in signal activation by LH and hCG are mediated by the LH\/CG receptor\u2019s extracellular hinge region","volume":"6","author":"Grzesik","year":"2015","journal-title":"Front Endocrinol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1210\/endo-108-5-1931","article-title":"Differential binding affinities of rat testis luteinizing hormone (LH) receptors for human chorionic gonadotropin, human LH, and ovine LH","volume":"108","author":"Huhtaniemi","year":"1981","journal-title":"Endocrinology"},{"key":"B29","first-page":"331","article-title":"Differential response to sustained stimulation by hCG & LH on goat ovarian granulosa cells","volume":"135","author":"Gupta","year":"2012","journal-title":"Indian J Med Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S1043-2760(99)00164-2","article-title":"Crosstalk among multiple signaling pathways controlling ovarian cell death","volume":"10","author":"Amsterdam","year":"1999","journal-title":"Trends Endocrinol Metab"},{"key":"B31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.mce.2016.08.005","article-title":"beta-arrestins regulate gonadotropin receptor-mediated cell proliferation and apoptosis by controlling different FSHR or LHCGR intracellular signaling in the hGL5 cell line","volume":"437","author":"Casarini","year":"2016","journal-title":"Mol Cell Endocrinol"},{"key":"B32","first-page":"127","article-title":"Ovarian stimulation in ART \u2013 unwinding pressing issues","volume":"67","author":"Zech","year":"2015","journal-title":"Minerva Ginecol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.fertnstert.2010.12.025","article-title":"Endometrial morphology and modulation of hormone receptors during ovarian stimulation for assisted reproductive technology cycles","volume":"95","author":"Detti","year":"2011","journal-title":"Fertil Steril"},{"key":"B34","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/humupd\/dmw027","article-title":"Interactions between androgens, FSH, anti-Mullerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary","volume":"22","author":"Dewailly","year":"2016","journal-title":"Hum Reprod Update"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1093\/humrep\/dev119","article-title":"Differential effects of estrogen and progesterone on development of primate secondary follicles in a steroid-depleted milieu in vitro","volume":"30","author":"Ting","year":"2015","journal-title":"Hum Reprod"},{"key":"B36","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1477-7827-12-95","article-title":"A review of luteinising hormone and human chorionic gonadotropin when used in assisted reproductive technology","volume":"12","author":"Ezcurra","year":"2014","journal-title":"Reprod Biol Endocrinol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1477-7827-8-112","article-title":"Recombinant human follicle-stimulating hormone produces more oocytes with a lower total dose per cycle in assisted reproductive technologies compared with highly purified human menopausal gonadotrophin: a meta-analysis","volume":"8","author":"Lehert","year":"2010","journal-title":"Reprod Biol Endocrinol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"CD001750","DOI":"10.1002\/14651858.CD001750.pub4","article-title":"Gonadotrophin-releasing hormone antagonists for assisted reproductive technology","volume":"4","author":"Al-Inany","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"B39","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.rbmo.2012.11.001","article-title":"GnRH agonist versus GnRH antagonist in ovarian stimulation: an ongoing debate","volume":"26","author":"Orvieto","year":"2013","journal-title":"Reprod Biomed Online"},{"key":"B40","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.fertnstert.2007.03.007","article-title":"GnRH agonist versus GnRH antagonist in ovarian stimulation: the influence of body mass index on in vitro fertilization outcome","volume":"89","author":"Rabinson","year":"2008","journal-title":"Fertil Steril"},{"key":"B41","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.fertnstert.2009.03.027","article-title":"What is the optimum maximal gonadotropin dosage used in microdose flare-up cycles in poor responders?","volume":"94","author":"Berkkanoglu","year":"2010","journal-title":"Fertil Steril"},{"key":"B42","doi-asserted-by":"publisher","first-page":"107","DOI":"10.5812\/ijem.5034","article-title":"GnRH analogues in the prevention of ovarian hyperstimulation syndrome","volume":"11","author":"Alama","year":"2013","journal-title":"Int J Endocrinol Metab"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/j.fertnstert.2005.02.011","article-title":"Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow?","volume":"83","author":"Fauser","year":"2005","journal-title":"Fertil Steril"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.fertnstert.2012.07.1164","article-title":"Best practices of ASRM and ESHRE: a journey through reproductive medicine","volume":"98","author":"Gianaroli","year":"2012","journal-title":"Fertil Steril"},{"key":"B45","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/humupd\/dmt037","article-title":"Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice","volume":"20","author":"La Marca","year":"2014","journal-title":"Hum Reprod Update"},{"key":"B46","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.fertnstert.2009.04.022","article-title":"A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the fast track and standard treatment (FASTT) trial","volume":"94","author":"Reindollar","year":"2010","journal-title":"Fertil Steril"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e1571","DOI":"10.1016\/j.fertnstert.2014.03.012","article-title":"A randomized clinical trial to determine optimal infertility treatment in older couples: the Forty and Over Treatment Trial (FORT-T)","volume":"101","author":"Goldman","year":"2014","journal-title":"Fertil Steril"},{"key":"B48","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.fertnstert.2015.10.032","article-title":"Costs of achieving live birth from assisted reproductive technology: a comparison of sequential single and double embryo transfer approaches","volume":"105","author":"Crawford","year":"2016","journal-title":"Fertil Steril"},{"key":"B49","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1093\/humrep\/dew360","article-title":"Efficacy and safety of follitropin alfa\/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders","volume":"32","author":"Humaidan","year":"2017","journal-title":"Hum Reprod"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmw001","article-title":"Trends in \u2019poor responder\u2019 research: lessons learned from RCTs in assisted conception","volume":"22","author":"Papathanasiou","year":"2016","journal-title":"Hum Reprod Update"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fendo.2017.00114\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T23:51:17Z","timestamp":1496274677000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fendo.2017.00114\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,1]]},"references-count":50,"alternative-id":["10.3389\/fendo.2017.00114"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2017.00114","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,1]]},"article-number":"114"}}